IS5534A - Ný notkun staðdeyfandi efna gegn æðahöfuðverkjum - Google Patents

Ný notkun staðdeyfandi efna gegn æðahöfuðverkjum

Info

Publication number
IS5534A
IS5534A IS5534A IS5534A IS5534A IS 5534 A IS5534 A IS 5534A IS 5534 A IS5534 A IS 5534A IS 5534 A IS5534 A IS 5534A IS 5534 A IS5534 A IS 5534A
Authority
IS
Iceland
Prior art keywords
headache
local anesthetic
new use
anesthetic agents
agents
Prior art date
Application number
IS5534A
Other languages
English (en)
Icelandic (is)
Inventor
Dalsgaard Carl-Johan
Eek Arne
Waldenlind Lennart
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS5534A publication Critical patent/IS5534A/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IS5534A 1997-12-19 2000-06-15 Ný notkun staðdeyfandi efna gegn æðahöfuðverkjum IS5534A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704770A SE9704770D0 (sv) 1997-12-19 1997-12-19 New use
PCT/SE1998/002299 WO1999032103A1 (en) 1997-12-19 1998-12-14 New use of local anaesthetics against vascular headaches

Publications (1)

Publication Number Publication Date
IS5534A true IS5534A (is) 2000-06-15

Family

ID=20409476

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5534A IS5534A (is) 1997-12-19 2000-06-15 Ný notkun staðdeyfandi efna gegn æðahöfuðverkjum

Country Status (18)

Country Link
EP (1) EP1047412A1 (de)
JP (1) JP2001526217A (de)
KR (1) KR20010024768A (de)
CN (1) CN1282241A (de)
AU (1) AU1898199A (de)
BR (1) BR9813775A (de)
CA (1) CA2314452A1 (de)
EE (1) EE200000394A (de)
HU (1) HUP0100599A3 (de)
ID (1) ID26703A (de)
IL (1) IL136518A0 (de)
IS (1) IS5534A (de)
NO (1) NO20003138L (de)
PL (1) PL341283A1 (de)
SE (1) SE9704770D0 (de)
SK (1) SK7832000A3 (de)
TR (1) TR200001926T2 (de)
WO (1) WO1999032103A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432986B2 (en) 1997-07-21 2002-08-13 Bruce H. Levin Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
AU2862200A (en) 1999-01-27 2000-08-18 Bruce H. Levin Compositions, kits, apparatus, and methods for inhibiting cerebral neurovasculardisorders and muscular headaches
WO2001043733A2 (en) * 1999-12-15 2001-06-21 Levin Bruce H Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
JP6568099B2 (ja) 2014-03-21 2019-08-28 テバ・ファーマシューティカルズ・インターナショナル・ゲーエムベーハーTeva Pharmaceuticals International GmbH カルシトニン遺伝子関連ペプチドに対するアンタゴニスト抗体及びその使用方法
EA201890578A1 (ru) * 2015-09-24 2018-12-28 Тева Фармасьютикалз Интернэшнл Гмбх Предотвращение, лечение и снижение (персистирующей) посттравматической головной боли
CA3036632A1 (en) 2016-09-23 2018-03-29 Teva Pharmaceuticals International Gmbh Treating refractory migraine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH380746A (de) * 1958-11-06 1964-08-15 Ciba Geigy Verfahren zur Herstellung neuer sekundärer Amine
US3988475A (en) * 1974-02-05 1976-10-26 Istituto Luso Farmaco D'italia S.R.L. Phenoxyalkylamines
AR004691A1 (es) * 1995-10-27 1999-03-10 Astrazeneca Ab Nuevos derivados de [3-alcoxi-fenoxi-)-etil]-dialquilamina, una composicion farmaceutica que los comprende, su uso como anestesicos locales y unprocedimiento para su preparacion

Also Published As

Publication number Publication date
CN1282241A (zh) 2001-01-31
HUP0100599A3 (en) 2002-04-29
EP1047412A1 (de) 2000-11-02
NO20003138D0 (no) 2000-06-16
KR20010024768A (ko) 2001-03-26
TR200001926T2 (tr) 2000-11-21
SK7832000A3 (en) 2001-02-12
IL136518A0 (en) 2001-06-14
ID26703A (id) 2001-02-01
PL341283A1 (en) 2001-04-09
BR9813775A (pt) 2000-10-10
JP2001526217A (ja) 2001-12-18
CA2314452A1 (en) 1999-07-01
NO20003138L (no) 2000-08-18
AU1898199A (en) 1999-07-12
SE9704770D0 (sv) 1997-12-19
EE200000394A (et) 2001-12-17
HUP0100599A2 (hu) 2002-02-28
WO1999032103A1 (en) 1999-07-01

Similar Documents

Publication Publication Date Title
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
FI970310A (fi) 4-indolijohdannaiset serotoniinin vaikuttaja- ja vastavaikuttaja-aineina
NO993068D0 (no) Ny forbindelsesform
NO992806L (no) Terapeutiske midler
DK1027332T3 (da) Hidtil ukendte lactametalloproteaseinhibitorer
ID18679A (id) Penggunaan terapi lanjutan
NO20001847L (no) Ny anvendelse av forbindelser for anti-kløe-aktivitet
NO993298D0 (no) Ny fremgangsmÕte
EE04439B1 (et) 5HT1 antagonistid antidepressantraviks
ID21424A (id) Konfigurasi katup gabungan untuk unit siklus-uap
NO995796L (no) Ny fremgangsmåte
IS5534A (is) Ný notkun staðdeyfandi efna gegn æðahöfuðverkjum
EE9600160A (et) Kinoliin-3-karboksamiidi ühendite kasutamine uuel otstarbel
NO993438D0 (no) Kontrastmidler for ultralyd
EE9600127A (et) Kinoliin-3-karboksamiidi ühendite kasutamine uuel otstarbel
IS5814A (is) Ný lyfjafræðileg notkun á NOS lötum
IS4320A (is) Ný súbstitúeruð bensimidasól
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
FI974235A0 (fi) Ny bestaemningsmetod
ID24521A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
SE9702595D0 (sv) new therapeutic use
FI970807A (fi) Tiosemikarbatsidien käyttö lahonestoaineina
BR1101089A (pt) Composição terapêutica de uso nasal
SE9802023D0 (sv) New therapeutic use
SE9402421D0 (sv) New use